Cargando…
Medicines availability for non-communicable diseases: the case for standardized monitoring
BACKGROUND: In response to the global burden of non-communicable diseases (NCDs), the World Health Organization (WHO) has developed a Global Action Plan that includes a voluntary medicines target of 80% availability and affordability of essential medicines for the prevention and treatment of diabete...
Autores principales: | Robertson, Jane, Macé, Cécile, Forte, Gilles, de Joncheere, Kees, Beran, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427979/ https://www.ncbi.nlm.nih.gov/pubmed/25947094 http://dx.doi.org/10.1186/s12992-015-0105-0 |
Ejemplares similares
-
Erratum to: Medicines availability for non-communicable diseases: the case for standardized monitoring
por: Robertson, Jane, et al.
Publicado: (2015) -
The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?
por: Magrini, Nicola, et al.
Publicado: (2015) -
Tough decisions on essential medicines in 2015
por: Magrini, Nicola, et al.
Publicado: (2015) -
Noncommunicable diseases, access to essential medicines and universal health coverage
por: Beran, David, et al.
Publicado: (2019) -
Medicine Availability and Prescribing Policy for Non-Communicable Diseases in the Western Balkan Countries
por: Pekez-Pavlisko, Tanja, et al.
Publicado: (2017)